In a landmark development for UK otology, Emma Stapleton, consultant otolaryngologist at Manchester University NHS Foundation Trust, has successfully performed the nation’s first cochlear implantation utilising the cutting-edge OTODRIVE and OTOARM systems.
These innovations, developed collaboratively by hearing implant leader MED-EL and medical engineering firm CASCINATION AG, aim to improve surgical control and reproducibility while maintaining the essential human elements of microsurgical technique.
OTODRIVE provides precise electrode insertion with controlled movement, capable of slow speeds as low as 0.1 mm/s, facilitating accurate navigation of the cochlear canal.
OTOARM provides stable, tremor-reduced positioning of surgical instruments, promoting ergonomic efficiency and consistency.
Dr Stapleton highlighted the system’s ease of integration: ‘It’s a streamlined setup that attaches easily to the operating table and interfaces seamlessly with the operating microscope, adding minimal operative time."
Patient-centred insights indicate improved safety and tissue preservation, with potential benefits including reduced cochlear trauma, preservation of residual hearing, and protection of delicate inner ear structures.
This milestone at Manchester Royal Infirmary aligns with a global shift toward robotic and machine-assisted cochlear implantation, positioning the UK among leading centres utilising precision tools to optimise outcomes.
For technical details on OTODRIVE and OTOARM, visit: https://blog.medel.com/technology/cochlear-implant-surgery/
